Our portfolio company #1 Mekonos has announced an exciting partnership to build designer chromosomes as part of the next generation of cell therapy. These therapies are the key to personalised…
We are proud to have participated in Mekonos' latest capital raise as we continue to support their ongoing development, stemming from research originally conducted at the University of Canterbury. Below…
Congratulations to the Mekonos team, who have been identified and recognised on a list of top Life Science start-ups based in San Francisco: https://beststartup.us/42-top-san-francisco-life-science-companies-and-startups-of-2021/
Anil Narasimha, CEO of Mekonos, has given a great interview about how he got started with a career in Life Sciences, provided insights into Mekonos and its achievements, and talked…
Anil Narasimha, the CEO of our portfolio company Mekonos, has done an interview with Dan Gonzales and Earl Valencia on the Startup Mindsets podcast, discussing entrepreneurship in the biology space…
Our portfolio company Mekonos has formally closed its US$4.6mil capital raise, led by Novartis with participation from a number of US institutional VC Funds as well as Matū Fund. The…
Andressen Horowitz has produced an interesting podcast episode about the recent Nobel Prize in Chemistry awarded to two researchers behind CRISPR, exploring When, Who, How, and What Now. They look…